“The apprehension with working with non IID mentioned ingredients is justified as it truly is difficult To judge if FDA would find the ‘novel excipient’ Safe and sound to be used in the drug product as there is no outlined process for analysis and approval of excipients. The FDA https://gastonf368tqk1.wikitron.com/user